|
|
Centre’s PLI scheme gives booster shot to pharma and medtech sector
IANS | 25 Sep, 2026
The Production-Linked Incentive (PLI) schemes have succeeded in strengthening India’s pharmaceutical, bulk drugs and medical devices manufacturing ecosystem, which has helped to reduce import dependence and encouraged technology adoption to build globally competitive capabilities in the pharma and medtech sector, according to a factsheet issued by the government on Friday.
|
|
|
|
|
| |
|